|
PDHX expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
4.358700E-04 |
| Normal-vs-Stage3 |
1.62447832963153E-12 |
| Normal-vs-Stage4 |
1.704525409707E-12 |
| Stage1-vs-Stage2 |
2.523800E-01 |
| Stage1-vs-Stage3 |
6.819500E-03 |
| Stage1-vs-Stage4 |
2.600400E-01 |
| Stage2-vs-Stage3 |
2.491700E-02 |
| Stage2-vs-Stage4 |
9.985600E-02 |
| Stage3-vs-Stage4 |
4.968400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
2.53130849614536E-14 |
| Normal-vs-Asian |
1.23600000012658E-07 |
| Caucasian-vs-AfricanAmerican |
6.560200E-01 |
| Caucasian-vs-Asian |
5.653200E-01 |
| AfricanAmerican-vs-Asian |
6.000600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
5.719000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.82520665248376E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.99840144432528E-15 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.356200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.395200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.519000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.727000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.843900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.019900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.03630000031418E-07 |
| Normal-vs-Grade 2 |
1.62436730732907E-12 |
| Normal-vs-Grade 3 |
<1E-12 |
| Normal-vs-Grade 4 |
1.93067783982315E-13 |
| Grade 1-vs-Grade 2 |
7.277400E-01 |
| Grade 1-vs-Grade 3 |
2.663000E-01 |
| Grade 1-vs-Grade 4 |
1.617420E-01 |
| Grade 2-vs-Grade 3 |
3.576200E-02 |
| Grade 2-vs-Grade 4 |
1.096620E-01 |
| Grade 3-vs-Grade 4 |
7.796600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.11022302462516E-16 |
| Normal-vs-ccB subtype |
1.63091762317435E-12 |
| ccA subtype-vs-ccB subtype |
4.579000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
2.79639977840418E-10 |
| N0-vs-N1 |
5.009200E-01 |
|
|
